Sanofi India reports second quarter net profit at Rs 178.3 crore

Revenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration

Sanofi
Press Trust of India New Delhi
1 min read Last Updated : Jul 27 2021 | 5:21 PM IST

Drug firm Sanofi India on Tuesday reported a net profit of Rs 178.3 crore for the second quarter ended in June.

The company had posted a net profit of Rs 136.3 crore for the corresponding period of the previous financial year, Sanofi India said in a regulatory filing.

Revenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration. It was Rs 710.5 crore for the same period a year ago, it added.

"On account of Ankleshwar manufacturing facility transfer to Zentiva, export sales reduced in the current period and accordingly the export sales performance for the quarter and period ended June 30, 2021, is not comparable with quarter and period ended June 30, 2020," Sanofi India said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Sanofi IndiaDrug firmsPharma sector

First Published: Jul 27 2021 | 5:20 PM IST

Next Story